Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial.
暂无分享，去创建一个
W. Feng | Xiaoqing Liu | Yunpeng Liu | Gang Wu | Yanqiu Zhao | Wei Song | N. Wu | Yiping Zhang | Shucai Zhang | K. Ma | Yi Hu | Jun Zhao | G. Selvaggi | Jifeng Feng | Li Zhang | Yong Song | Yun-peng Yang | Yun Fan | Jianying Zhou | W. Zhong | Chengzhi Zhou | Jianya Zhou | Y. Gong | Zhuang Yu | W. Zhuang | Yubiao Guo | Yuan Chen | Jianhua Chen | Gaofeng Li | Lejie Cao | Xiaobin Yuan | L. Ding | L. Mao | Tao Wang | Shijun Zhao | Yuanqing Fu | F. Ye | Zhendong Zheng | S. Xiao | J. Fang | Jianying Zhou | X. Yuan | Zhuang Wu